|
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Human cholestryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors.
|
17587762 |
2007 |
|
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Polymorphisms in the hepatic lipase (LIPC -514C > T) and cholesteryl ester transfer protein (CETP I405V) genes affect high-density lipoprotein cholesterol (HDL-c) levels, but their relationship with cardiovascular disease and their combined effect is unclear.
|
17440012 |
2007 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
CTD_human |
Candidate gene polymorphism in cardiovascular disease: the BIP cohort.
|
16544732 |
2006 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
LHGDN |
CETP levels rather than polymorphisms as markers of coronary risk: healthy athlete with high HDL-C and coronary disease--effectiveness of probucol.
|
16563399 |
2006 |
|
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
LHGDN |
TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
|
15856070 |
2005 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
LHGDN |
To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
|
15939053 |
2005 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
These results replicate some earlier findings and also help to explain some of the apparent contradictions in the literature surrounding the role of CETP in modulating HDL-C and cardiovascular disease.
|
15939053 |
2005 |
|
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
|
15856070 |
2005 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Cholesteryl ester transfer protein (CETP) is an important modulator of high density lipoprotein cholesterol in humans and thus considered to be a therapeutic target for preventing cardiovascular disease.
|
15681846 |
2005 |
|
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
In terms of new information, three topics are presented: (1) new findings related to classical candidate genes, such as apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase; (2) recent reports related to new loci that have joined the growing list of cardiovascular disease candidate genes (i.e.
|
12544661 |
2003 |
|
Cardiovascular Diseases
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Since the identification of cholesteryl ester transfer protein (CETP), its role in the modulation of HDL levels and cardiovascular disease has been debated.
|
12639975 |
2003 |
|
Cardiovascular Diseases
|
0.400 |
GeneticVariation
|
group |
BEFREE |
In the field of lipoprotein metabolism and cardiovascular disease several gene polymorphisms for key proteins, such as apoproteins (apo) E, B, A-IV and C-III, LDL receptor, microsomal transfer protein (MTP), fatty acid-binding protein (FABP), cholesteryl ester transfer protein (CETP), lipoprotein lipase and hepatic lipase, have been identified and linked to variable responses to diets.
|
12691171 |
2002 |